Why us?
We believe that AI holds the key to drastically improve how cancer and other complex diseases are diagnosed and treated. Our vision is simple: We want to beat cancer by revolutionizing the analysis of tissue samples with machine learning.
Aignostics is a spin-off from Europe's largest university hospital (Charité) and Berlin's Technical University, with offices in Berlin and Boston. We have received ~€20m in funding from blue chip investors and are a growing team of over 100 interdisciplinary professionals. We work with academic partners as well as leading pharma and biotech companies in Europe and the US.
This is a unique opportunity to join a fun, diverse and fast-growing team to work on problems that really matter, while being embedded in an exciting mix of scientific research and medical device development.
Aignostics is a spin-off from Europe's largest university hospital (Charité) and Berlin's Technical University, with offices in Berlin and Boston. We have received ~€20m in funding from blue chip investors and are a growing team of over 100 interdisciplinary professionals. We work with academic partners as well as leading pharma and biotech companies in Europe and the US.
This is a unique opportunity to join a fun, diverse and fast-growing team to work on problems that really matter, while being embedded in an exciting mix of scientific research and medical device development.